Iobenguane Completed Phase 1 Trials for Neuroendocrine Tumors / Heart Failure Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic1
clinicaltrials.gov IdentifierTitleDrugs
NCT01730417Phase I Study of the Safety, Distribution, and Radiation Dosimetry of Ultratrace Iobenguane 123I-mIBG